Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: J Thromb Haemost. 2021 Apr 12;19(7):1709–1717. doi: 10.1111/jth.15282

Figure 1.

Figure 1.

Effect of simvastatin and placebo on (A) tissue factor procoagulant activity (TF-PCA), (B) tissue factor pathway inhibitor (TFPI) and (C) factor VII coagulant activity (FVIIC). Shown are mean ± SEM for patients (n=108–113) in the placebo and the simvastatin (n=108–114) groups. The p-values shown are for change over time in the placebo or statin group. TFPI levels were different between placebo and statin groups (p<0.0001) and this is shown. TF-PCA and FVIIC levels were not different between the two groups.